Cladosporium keratitis - a case report and literature review

Steve Chih-Hsuan Cheng1, Ying-Yu Lin2, Chien-Neng Kuo3,4

  • 1Department of Medical Education, Chang Gung Memorial Hospital, No.6, W. Sec., Chia-Pu Rd., Puzi City, Chiayi County, 61363, Taiwan. stevecheng@cgmh.org.tw.

BMC Ophthalmology
|August 20, 2015
PubMed
Abstract

Insights

Fungal keratitis, a serious eye infection, can lead to blindness. Voriconazole is a promising treatment for Cladosporium keratitis, a rare fungal infection, especially when other antifungals fail.

Area of Science:

  • Ophthalmology
  • Mycology
  • Infectious Diseases

Background:

  • Fungal keratitis is a significant cause of infectious blindness in tropical regions.
  • Common causative agents include Candida, Fusarium, and Aspergillus species.
  • Cladosporium keratitis presents a rare but challenging clinical scenario due to limited topical antifungal options.

Observation:

  • A 62-year-old male presented with severe ocular pain, blurred vision, and corneal ulceration with feathery margins.
  • Initial treatment with topical natamycin, amphotericin B, fluconazole, and oral ketoconazole proved ineffective.
  • Corneal cultures confirmed the presence of Cladosporium species.

Findings:

  • Voriconazole, administered both topically and systemically, successfully controlled the Cladosporium keratitis.
  • This case highlights the potential efficacy of voriconazole in treating rare fungal corneal infections.

Implications:

  • Voriconazole represents a viable therapeutic option for recalcitrant Cladosporium keratitis.
  • Further research is warranted to establish optimal treatment protocols for rare fungal keratitis.
  • This case contributes to the understanding of managing challenging fungal eye infections.

Related Concept Videos